Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company is headquartered in New York, New York. Show more

345 PARK AVENUE SOUTH, NEW YORK, NY, UNITED STATES, 10010, New York, NY, 10010, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

401.2M

52 Wk Range

$3.99 - $10.99

Previous Close

$4.84

Open

$4.76

Volume

296,442

Day Range

$4.76 - $4.99

Enterprise Value

180.7M

Cash

92.83M

Avg Qtr Burn

-17.6M

Insider Ownership

0.64%

Institutional Own.

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
LX2006 Details Friedreich’s Ataxia	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LX2020 Details Arrhythmogenic cardiomyopathy	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LX1001 Details Alzheimer's disease	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.